Cargando…

Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells

Malignant melanoma is a lethal skin cancer containing melanoma-initiating cells (MIC) implicated in tumorigenesis, invasion, and drug resistance, and is characterized by the elevated expression of stem cell markers, including CD133. The siRNA knockdown of CD133 enhances apoptosis induced by the MEK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simbulan-Rosenthal, Cynthia M., Haribabu, Yogameenakshi, Vakili, Sahar, Kuo, Li-Wei, Clark, Havens, Dougherty, Ryan, Alobaidi, Ryyan, Carney, Bonnie, Sykora, Peter, Rosenthal, Dean S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877091/ https://www.ncbi.nlm.nih.gov/pubmed/35216449 http://dx.doi.org/10.3390/ijms23042333

Ejemplares similares

CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019)

CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019)

Hypopigmented burn hypertrophic scar contains melanocytes that can be signaled to re-pigment by synthetic alpha-melanocyte stimulating hormone in vitro
por: Carney, Bonnie C., et al.
Publicado: (2021)

Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen
por: Glinkina, Kseniya, et al.
Publicado: (2022)

CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
por: Castells-Roca, Laia, et al.
Publicado: (2021)

Employing the CRISPR-Cas System for Clonal Hematopoiesis Research
por: Ogawa, Hayato, et al.
Publicado: (2021)

Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
por: SHARMA, BHUVNESH K., et al.
Publicado: (2012)

Inorganic polyphosphate in platelet rich plasma accelerates re-epithelialization in vitro and in vivo
por: Carney, Bonnie C., et al.
Publicado: (2020)

Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
por: Jeong, Song Hee, et al.
Publicado: (2023)

A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
por: Gilad, Yosi, et al.
Publicado: (2021)

Employing CRISPR/Cas Technology for the Improvement of Potato and Other Tuber Crops
por: Tussipkan, Dilnur, et al.
Publicado: (2021)

Unintended on-target chromosomal instability following CRISPR/Cas9 single gene targeting
por: Przewrocka, J., et al.
Publicado: (2020)

Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Dong, Chen, et al.
Publicado: (2018)

Quantitative evaluation of incomplete preweaning lethality in mice by using the CRISPR/Cas9 system
por: Nakamura, Takumi, et al.
Publicado: (2018)

The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity
por: Sapozhnikov, Daniel M., et al.
Publicado: (2023)

Skin Immuno-CometChip in 3D vs. 2D Cultures to Screen Topical Toxins and Skin-Specific Cytochrome Inducers
por: Rosenthal, Dean S., et al.
Publicado: (2023)

Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition
por: Wang, Chao, et al.
Publicado: (2018)

Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs
por: Tang, Shan, et al.
Publicado: (2022)

Modeling synthetic lethality
por: Le Meur, Nolwenn, et al.
Publicado: (2008)

Author Correction: Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Dong, Chen, et al.
Publicado: (2018)

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations
por: Li, Wenqian, et al.
Publicado: (2022)

CRISPR/Cas9-Mediated Knock-Out of dUTPase in Mice Leads to Early Embryonic Lethality
por: Pálinkás, Hajnalka Laura, et al.
Publicado: (2019)

CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition
por: Li, Wanlu, et al.
Publicado: (2019)

Synthetic CRISPR/Cas9 reagents facilitate genome editing and homology directed repair
por: DiNapoli, Sara E, et al.
Publicado: (2020)

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
por: Chou-Zheng, Lucy, et al.
Publicado: (2019)

Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification
por: Jia, Yubin, et al.
Publicado: (2023)

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal
por: Krill-Burger, J. Michael, et al.
Publicado: (2023)

DNA repair and synthetic lethality
por: Guo, Gong-she, et al.
Publicado: (2011)

Synthetic Lethality in Ovarian Cancer
por: Chandrasekaran, Akshaya, et al.
Publicado: (2021)

A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro
por: Li, Jianfa, et al.
Publicado: (2019)

Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
por: Feng, Junru, et al.
Publicado: (2022)

Creating highly efficient resistance against wheat dwarf virus in barley by employing CRISPR/Cas9 system
por: Kis, András, et al.
Publicado: (2019)

MISSA 2.0: an updated synthetic biology toolbox for assembly of orthogonal CRISPR/Cas systems
por: Zhang, Hai-Yan, et al.
Publicado: (2017)

Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
por: Wang, Hong, et al.
Publicado: (2018)

Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC
por: Kwon, Deborah Y., et al.
Publicado: (2017)

Toward a translationally independent RNA-based synthetic oscillator using deactivated CRISPR-Cas
por: Kuo, James, et al.
Publicado: (2020)

A fly model establishes distinct mechanisms for synthetic CRISPR/Cas9 sex distorters
por: Fasulo, Barbara, et al.
Publicado: (2020)

CRISPR-Cas12a Possesses Unconventional DNase Activity that Can Be Inactivated by Synthetic Oligonucleotides
por: Li, Bin, et al.
Publicado: (2020)

Synthetic Circular gRNA Mediated Biological Function of CRISPR-(d)Cas9 System
por: Wang, Mingxia, et al.
Publicado: (2022)

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications
por: Spalato-Ceruso, M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6vltv6vl2dqluo0drpufhqb5s4